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Abstract
Background: Human primary myotubes are highly glycolytic when cultured in high glucose medium rendering it difficult to
study mitochondrial dysfunction. Galactose is known to enhance mitochondrial metabolism and could be an excellent
model to study mitochondrial dysfunction in human primary myotubes. The aim of the present study was to 1) characterize
the effect of differentiating healthy human myoblasts in galactose on oxidative metabolism and 2) determine whether
galactose can pinpoint a mitochondrial malfunction in post-diabetic myotubes.
Methodology/Principal Findings: Oxygen consumption rate (OCR), lactate levels, mitochondrial content, citrate synthase
and cytochrome C oxidase activities, and AMPK phosphorylation were determined in healthy myotubes differentiated in
different sources/concentrations of carbohydrates: 25 mM glucose (high glucose (HG)), 5 mM glucose (low glucose (LG)) or
10 mM galactose (GAL). Effect of carbohydrates on OCR was also determined in myotubes derived from post-diabetic
patients and matched obese non-diabetic subjects. OCR was significantly increased whereas anaerobic glycolysis was
significantly decreased in GAL myotubes compared to LG or HG myotubes. This increased OCR in GAL myotubes occurred in
conjunction with increased cytochrome C oxidase activity and expression, as well as increased AMPK phosphorylation. OCR
of post-diabetic myotubes was not different than that of obese non-diabetic myotubes when differentiated in LG or HG.
However, whereas GAL increased OCR in obese non-diabetic myotubes, it did not affect OCR in post-diabetic myotubes,
leading to a significant difference in OCR between groups. The lack of an increase in OCR in post-diabetic myotubes
differentiated in GAL was in relation with unaltered cytochrome C oxidase activity levels or AMPK phosphorylation.
Conclusions/Significance: Our results indicate that differentiating human primary myoblasts in GAL enhances aerobic
metabolism. Because this cell culture model elicited an abnormal response in cells from post-diabetic patients, it may be
useful in further studies of the molecular mechanisms of mitochondrial dysfunction.
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Introduction
Human primary muscle cells are a widely used model system to
study muscle metabolism and its related disorders. Cell culture of
human primary myotubes offers not only an excellent and dynamic
model for studying metabolism under standardized conditions, but
provides an excellent system for studying metabolic disorders.Indeed,
a number of studies have shown that human primary muscle cells
retain the same metabolic phenotype as those previously evidenced in
vivo in muscle [1,2,3,4,5,6,7,8,9,10,11]. The oxidative capacity of
skeletal muscle is highly influenced by various genetic and
environmental factors; cultured myotubes offer a unique model that
separates these two influences on metabolic phenotype [7].
Although a valuable model system, cultured muscle cells are
highly glycolytic when grown and differentiated under high
glucose conditions relative to muscle tissue in vivo [12], complicat-
ing the study of mitochondrial dysfunction. Indeed, myoblasts are
routinely cultured in a standard high glucose medium which can
diminish mitochondrial function. In the same way, rapidly
proliferating cancer cells are known to be highly glycolytic when
grown in high glucose conditions [13,14,15], a phenomenon
known as the Crabtree effect, when glucose inhibits oxidative
phosphorylation [16]. This phenomenon is not restricted to cancer
cells. Other types of cells including embryonic tissues [17] and
proliferative thymocytes [18] show diminished oxidative metabo-
lism when grown under high glucose conditions.
Whereas the production of pyruvate via glycolytic metabolism
of glucose yields 2 net ATP, the production of pyruvate via
glycolytic metabolism of galactose yields no net ATP, forcing cells
to have an increased reliance on oxidative phosphorylation
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cells (e.g., cancer cells, primary fibroblasts) grown in a medium in
which glucose is replaced with galactose show a significantly
increased oxygen consumption rate compared to cells grown in
medium containing a high concentration of glucose (25 mM)
[13,14,15]. The more aerobic state of cells grown in galactose is
mainly due to a decrease in ATP production via anaerobic
glycolysis [22] but is also thought to be due to a modulation of
mitochondrial structure [15] and an increase in mitochondrial
oxidative capacity as evidenced by increased OXPHOS protein
expression and mitochondrial enzymatic activities [15]. Since cells
grown in galactose rely mostly on oxidative phosphorylation to
produce their ATP, they become more sensitive to mitochondrial
toxins than cells grown in high glucose medium [13,23,24].
Another study has shown that primary skin fibroblasts isolated
from patients with mitochondrial deficiency (e.g., cytochrome
oxidase deficiency, complex I deficiency, pyruvate dehydrogenase
complex deficiency or with multiple respiratory chain defects) were
not able to survive when cultured in a galactose-based medium
[20]. Thus, culturing cells in a galactose medium seems to be a
good alternative to high glucose medium in order to study
mitochondrial dysfunction.
Obesity-associated insulin resistance and type 2 diabetes
mellitus (T2DM) is characterized by a decrease in mitochondrial
function. Mitochondrial respiration is known to be reduced in the
skeletal muscle of T2DM patients [25,26,27] and lean insulin-
resistant offspring of T2DM parents [28,29]. Some studies, done
on primary muscle cells derived from diabetic patients and
matched controls have also shown a decrease in mitochondrial
capacity: impaired ATP synthesis [30,31], perturbed palmitate
beta-oxidation when exposed to high level of palmitate [9], and
impaired citrate synthase activity [7]. However, to our knowledge,
no study has directly assessed whether myotubes derived from
T2DM patients or patients with a history of T2DM retain a
decrease in mitochondrial respiration when cultured in vitro.A s
mentioned above, this is most likely due to the fact that in vitro,
primary human myotubes are mainly glycolytic rendering difficult
the study of mitochondrial dysfunction in this model. The use of
galactose medium instead of glucose medium to induce a
metabolic shift towards a more oxidative phenotype could be a
good model to study mitochondrial dysfunction in relation to
T2DM and insulin resistance. However, to date, the response of
human primary muscle cells to galactose has never been assessed.
Here, we characterized the effect of replacing glucose with
galactose on aerobic metabolism in primary muscle cells derived
from lean and healthy donors. We have shown that differentiating
primary human muscle cells in a galactose-replete medium
enhances aerobic metabolism without altering mitochondrial
content. Moreover, we have shown that this model system can
be employed to investigate the mitochondrial bioenergetics of
human myotubes derived from post-diabetic patients. To our
knowledge, this is the first study that tests the impact of different
sources of carbohydrates on human myotube bioenergetics. The
value of this model system and its importance to investigating
mitochondrial dysfunction in cell culture is also discussed herein.
Results
Impact of different carbohydrates on cellular physiology
and ATP content
Glucose restriction has been shown to decrease myotube
differentiation [32]. The fusion index in cells differentiated in
high glucose (25 mM, HG), low glucose (5 mM, LG) or GAL was
not significantly different between the 3 differentiation conditions
(Fig. 1A). However, troponin T expression, which is another
marker of myotube differentiation, was significantly decreased in
cells differentiated in LG or GAL compared to cells differentiated
in HG (p,0.05, Fig. 1B). Yet, cells differentiated in GAL showed
the same level of differentiation than cells differentiating in LG.
After 7 days of differentiation in the different mediums, the
redox state of the cells was assessed using the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide) assay. A
significant decrease in the redox state was found in myotubes
differentiated in LG or GAL compared to HG (p,0.05), with no
difference between cells differentiated in LG and GAL (Fig. 1C).
We also measured ATP content in myotubes differentiated for 7
days in HG, LG or GAL. As shown in Figure 1D, no significant
difference was found in ATP content between myotubes
differentiated in the three types of media. Hence, these
observations indicate that replacing glucose with galactose does
not have a negative effect on cellular physiology and metabolism.
Replacing glucose with galactose in differentiation
medium increases myotube aerobic capacity
Primary human muscle cells differentiated in GAL showed a
,40% increase in basal mitochondrial oxygen consumption rate
(basal mitochondrial OCR=basal OCR – non-mitochondrial
OCR) compared to cells differentiated in either HG or LG
(p,0.05, Fig. 2A). Mitochondrial state 4 respiration (proton leak
dependent respiration=(OCR after oligomycin treatment – non-
mitochondrial OCR)) tended to be higher in GAL myotubes
compared to LG myotubes (p=0.07) or HG myotubes (p=0.1)
(Fig. 2B) without reaching significance. However, the percentage
of basal mitochondrial OCR due to proton leak was not
significantly different between treatments (Fig. 2C). There was
also a trend for a higher maximal mitochondrial OCR (measured
after FCCP treatment) in GAL cells compared to LG cells, but this
did not reach significance (p=0.07, Fig. 2D).
The non-mitochondrial OCR was measured by treating cells
with antimycin A. Intriguingly, OCR after antimycin A treatment
was significantly higher in myotubes differentiated in GAL
compared to myotubes differentiated in HG (p,0.01, Fig. 2E).
To test the metabolic changes accompanying differentiating
cells in GAL further, we measured the amount of lactate released
in the medium over a 24 h period. As shown in Figure 2F, cells
differentiated in GAL showed a significant decrease in lactate
production compared to cells differentiated in LG or HG
indicating a decrease in anaerobic metabolism in cells differenti-
ated in GAL (p,0.0001). No significant difference in lactate
production was found between myotubes differentiated in HG and
LG.
Taken together, these data confirm that myotubes differentiated
in presence of glucose are mostly glycolytic, and that the
replacement of glucose by galactose in the differentiation medium
forces cells to adopt a more oxidative metabolic state.
Effect of galactose on mitochondrial content and enzyme
activity
In order to determine if the increase in OCR shown in Figure 2
was the result of an increase in mitochondrial biogenesis, different
mitochondrial markers were measured. First, mitochondrial yield
was determined as mitochondria protein content per total cellular
protein content. As shown in Figure 3A, differentiating the cells in
GAL did not have any effect on mitochondrial yield compared to
myotubes differentiating in HG or LG. Another method to
determine mitochondrial content is the staining of cardiolipin with
10N-nonyl acridine orange (NAO). As shown on Figure 3B, this
Galactose Effects on Human Muscle Cell Metabolism
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GAL do not affect mitochondrial content. These results were
confirmed by measuring the protein levels of the mitochondrial
markers, complex III and SDHA. The levels of each protein were
not significantly affected by the different carbohydrate sources
(Fig. 3D).
The impact of differentiating cells in galactose on the activity of
citrate synthase and cytochrome C oxidase (COX) was also
examined. The activities were measured on isolated mitochondria
to determine whether the capacity of the TCA (tricarboxylic acid)
cycle or the electron transport chain was increased in GAL
myotubes, respectively. Citrate synthase activity was not changed
by GAL medium compared to either HG or LG medium (Fig. 3C).
However, COX activity was significantly higher in GAL myotubes
compared to both HG and LG myotubes (p,0.01, Fig. 3E). This
higher COX activity was in relation with a higher COX
expression level in myotubes differentiating in GAL compared to
LG or HG (p,0.05, Fig. 3F).
AMPK is a major metabolic sensor that is activated by an
increase in the ratio of AMP/ATP in order to restore energy status
of the cell trough the stimulation of ATP-producing processes (e.g.,
glucose uptake, fatty acid oxidation, and mitochondrial biogenesis)
[33,34] and the inhibition of ATP-consuming processes (fatty acid
synthesis, glycogen synthesis, and protein synthesis) [35,36,37]. To
determine if the differentiation of cells in GAL medium also affects
AMPK activity, we estimated AMPK activity by measuring
AMPK phosphorylation (P-AMPK) in cells differentiated in either
HG, LG or GAL for 7 days. As shown on Figure 3G, P-AMPK
was higher in cells differentiated in GAL compared to LG or HG
(p,0.05 for P-AMPK/b-actin; p=0.07 for P-AMPK/AMPK).
Acute exposure to galactose does not affect myotube
oxidative capacity
In order to determine if an acute treatment was sufficient to
improve the aerobic capacity of the myotubes, cells were
differentiated for 7 days in LG, and then incubated for 45 min
before measuring oxygen consumption in HG, LG or GAL media.
As shown in Figure 4, basal mitochondrial (Fig. 4A), mitochondrial
state 4 (Fig. 4B), and maximal mitochondrial OCR (Fig. 4C) were
unaffected by an acute treatment with GAL. Hence, these data
indicate that in order to induce a metabolic shift towards increased
oxidative metabolism, cells have to be exposed to GAL for a
prolonged period.
Post-diabetic myotubes show incapacity to increase their
oxidative metabolism when differentiated in galactose
medium
The observed effect of galactose on oxidative metabolism
prompted us to test the effect of this carbohydrate on the aerobic
function of muscle cells collected from patients with a history of
diabetes (post-diabetic patients). To test if myotubes derived
Figure 1. Effect of replacing a glucose medium with a galactose medium on myotube differentiation, redox environment and ATP
content. A. Fusion index was measured in myotubes differentiated in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose) media for
7 days. The fusion index has been measured as the number of nuclei in differentiated myotubes (.2 myonuclei) as the percentage of the total
number of nuclei in muscle cells (determined by a desmin immunofluorescence staining). Data are shown as mean 6 SEM, n=3. B. Myotube
differentiation was assessed by Troponin T expression after 7 days of differentiation in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM
galactose) media. Top panel: representative Western blot of Troponin T expression in myotubes differentiated for 7 days in HG (25 mM glucose), LG
(5 mM glucose) or GAL (10 mM galactose). Beta-actin was used as a loading control. Bottom panel: quantification by densitometry of Troponin T
expression. Results are normalized to beta-actin expression. Data are shown as mean 6 SEM, n=4. *, p,0.05, LG and GAL vs HG. C. Myotube redox
environment in response to differentiation in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose) was assessed using the MTT assay as
described in the Methods section. Data are presented as mean 6SEM, n=3, in which each condition was assessed in 6 replicates. D. ATP content in
myotubes differentiated for 7 days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose). Results are presented as means 6 SEM,
n=4, in which each condition was assessed in duplicate.
doi:10.1371/journal.pone.0028536.g001
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level of OCR, post-diabetic myotubes and their matched obese
non-diabetic myotubes were differentiated for 7 days in HG, LG
or GAL. When differentiated in LG or HG, post-diabetic
myotubes showed the same basal mitochondrial OCR as obese
non-diabetic myotubes (Fig. 5A). However, unlike obese non-
diabetic myotubes, basal mitochondrial OCR in post-diabetic
myotubes showed no response to GAL, leading to a significant
difference between groups (Fig. 5A; p,0.05). This interesting
result highlights a defect in mitochondrial function in post-
diabetic myotubes. Mitochondrial state 4 OCR (Fig. 5B) and
maximal mitochondrial capacity (Fig. 5C) were however not
differentially affected by GAL, or different between post-diabetic
myotubes and obese non-diabetic myotubes. Interestingly, non-
mitochondrial OCR (in the presence of saturating antimycin)
was significantly lower in post-diabetic myotubes compared to
obese non-diabetic myotubes in the 3 different conditions
(Fig. 5D).
Post-diabetic myotubes show no increases in COX
activity or P-AMPK when differentiated in galactose
medium compared to low or high glucose media
To identify why post-diabetic myotubes are incapable of
increasing oxidative metabolism in response to GAL, we measured
mitochondrial content, and COX expression and activity (Fig. 6).
Surprisingly, we found a significant increased mitochondrial yield
in post-diabetic myotubes differentiated in LG compared with
myotubes differentiated in both HG (p=0.05) and GAL (p,0.01)
(Fig. 6A). However, COX activity was not significantly different
between conditions due to the high variability in activity between
post-diabetic samples (Fig. 6B). Furthermore, COX expression was
not significantly increased when post-diabetic cells were differen-
tiated in GAL compared to LG or HG (Fig. 6C). We also
measured the level of P-AMPK in post-diabetic myotubes
differentiated in HG, LG or GAL. In contrast to control myotubes
(Figure 3G), post-diabetic myotubes did not show increased
AMPK phosphorylation in response to GAL medium (Fig. 6D).
Figure 2. Effect of replacing a glucose medium with a galactose medium on myotube aerobic capacity. A. Basal mitochondrial oxygen
consumption rate. *, p,0.05, GAL vs HG and LG. B. State 4 respiration (leak-dependent; non-phosphorylating). After basal oxygen consumption rate
measurement, cells were treated with oligomycin (600 ng/ml) to determine state 4 respiration. p=0.06, GAL vs LG. C. Percentage of basal OCR due to
proton leak was calculated from the data shown in Figure 2A and B. Data are presented as means 6 SEM, n=7, in which each condition was assessed
in 5–6 replicates. D. Maximal mitochondrial oxygen consumption capacity. After basal and state 4 respiration measurements, cells were treated with
FCCP (1 mM) to determine maximal oxygen consumption. *, p,0.05, GAL vs LG. E. Non-mitochondrial oxygen consumption rate. After basal, state
and maximal respiration measurements, cells were treated with antimycin (4 mM) to determine non-mitochondrial oxygen consumption. **, p,0.01,
GAL vs LG. F. Lactate concentration in the extracellular media of myotubes differentiated for 7 days in HG (25 mM glucose), LG (5 mM glucose) or
GAL (10 mM galactose). Results are presented as means 6 SEM, n=7, in which each condition was assessed in duplicate. ***, p,0.0001, GAL vs HG
and LG.
doi:10.1371/journal.pone.0028536.g002
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myotubes differentiated for 7 days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose). Mitochondrial yield was determined as
mitochondrial protein content per total cellular protein content. Results are presented as means 6 SEM, n=6, in which each condition was assessed
in duplicate. B. Cardiolipin staining in myotubes differentiated for 7 days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose).
Cardiolipin was stained with 10N-nonyl acridine orange (NAO, 1 mM) in fixed myotubes for 30 min. The intensity of the staining was then measured
by fluorescence. Results are presented as means 6 SEM, n=3. C. Citrate synthase activity measured on isolated mitochondria from myotubes
differentiated for 7 days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose). Results are presented as means 6 SEM, n=5, in which
each condition was assessed in duplicate. D. Left panel: representative Western blot of Complex III and SDHA expression in myotubes differentiated
for 7 days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose). Complex III and SDHA were used as a mitochondrial content marker
and beta-actin as a loading control. Right panels: quantification by densitometry of complex III and SDHA expressions. Data are presented normalized
to beta-actin expression. Data are shown as mean 6SEM, n=4. E. Cytochrome C oxidase activity measured in isolated mitochondria from myotubes
differentiated for 7 days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose). Results are presented as means 6 SEM, n=5, in which
each condition was assessed in duplicate. *, p,0.05, GAL vs HG and LG. F. Top panel: representative Western blot of Complex IV expression in
myotubes differentiated for 7 days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose). Beta-actin was used as a loading control.
Bottom panel: quantification by densitometry of complex IV expression. Data are presented normalized to beta-actin expression. Data are shown as
mean 6SEM, n=4. *, p,0.05, GAL vs HG and LG. G. Left panel: representative Western blot of P-AMPK expression in myotubes differentiated for 7
days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose). Beta-actin and AMPKa2 were used as loading controls. Right panels:
quantification by densitometry of P-AMPK. Data are presented normalized to beta-actin and AMPKa2 expression. Data are shown as mean 6SEM,
n=3. *, p,0.05, GAL vs HG and LG.
doi:10.1371/journal.pone.0028536.g003
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The present study identifies galactose differentiation medium as
a useful experimental system to analyze mitochondrial metabolism
in human primary muscle cells. Our findings demonstrate that this
system provides an effective method to elucidate mitochondrial
dysfunction in myotubes derived from post-diabetic patients. Our
main results show that OCR was 30% higher in healthy myotubes
differentiating in GAL compared to LG or HG media, which is
due, at least in part, to an increase in AMPK phosphorylation and
COX activity in GAL treated cells. When differentiated in LG or
HG media, post-diabetic myotubes had similar OCR as myotubes
derived from matched obese non-diabetic volunteers. Interesting-
ly, unlike obese non-diabetic myotubes, post-diabetic myotubes
were unable to increase their OCR in response to GAL medium.
Post-diabetic myotubes were also unable to increase AMPK
phosophorylation and COX activity when differentiated in GAL.
To our knowledge, this study is the first to show that the use of a
GAL medium is a simple means to increase OCR in human
primary muscle cells and to potentially identify mitochondrial
dysfunction.
To better characterize the effect of different carbohydrate
sources and/or concentration during cell culture, we first
determined the level of differentiation in myotubes differentiated
for 7 days in LG (5 mM glucose), HG (25 mM glucose) or GAL
(10 mM galactose). Myotubes differentiated in HG showed the
highest level of differentiation as indicated by troponin T
expression level, which is commonly used as a marker of muscle
cell differentiation [8,38]. Thus, we have confirmed in our model
(human primary muscle cells) that glucose availability can affect
the level of muscle cell differentiation as previously reported by
others [32] in muscle cell lines (C2C12) and mouse primary
muscle cells. However, there were no differences in the levels of
differentiation in myotubes differentiated in 5 mM glucose (LG)
compared to 10 mM galactose (GAL), showing that the metabolic
differences found between LG and GAL myotubes were not the
result of alteration in levels of differentiation.
As previously shown by others in different cell lines or primary
fibroblasts [13,14,15], replacing glucose with galactose in the
medium forces the cells to become more oxidative in order to
maintain ATP levels. In accordance with an increased oxidative
metabolism, differentiating the cells in GAL decreased anaerobic
metabolism as shown by the diminished generation of lactate. The
sharp decrease in lactate production by the myotubes differenti-
ated in GAL is not surprising since the production of pyruvate
through galactose metabolism yields no net ATP, forcing the cells
to rely on aerobic metabolism instead of anaerobic glycolysis to
produce ATP [13,19,20,21]. The increase in oxygen consumption
rate in cells differentiated in GAL was not due to an increase in
proton leak-dependent oxygen consumption rate as shown by the
proportion of total respiration that was due to proton leak. A trend
for a higher maximal respiration rate in myotubes differentiated in
GAL compared to LG was also found, but this did not reach
significance (p=0.07). The higher mitochondrial OCR in GAL
cells was not the result of an increase in mitochondrial content as
evidenced by the similar levels of various mitochondrial markers
(mitochondrial yield, cardiolipin staining, SDHA and complex III
expressions). Furthermore, citrate synthase activity, commonly
used as a marker of TCA cycle activity, was not affected by the
different sources of carbohydrates. Interestingly, this increase in
mitochondrial OCR was related to a ,70% increase in
mitochondrial COX activity certainly due to an increase in
COX expression. Our results on human primary muscle cells are
in accordance with a previous report showing increases in COX
expression and activity in HeLa cells grown in 10 mM galactose
compared to 25 mM glucose [15]. We also found an increased
AMPK phosphorylation in myotubes differentiated in GAL
compared to LG or HG. AMPK is a major metabolic sensor in
cells and is activated by increased AMP/ATP for the purpose of
restoring the energy status of the cell [33,34,35,36,37]. An increase
AMPK phosphorylation in response to a decrease in glucose
availability (25 mM compared to 5 mM) has also been found by
others in C2C12 myotubes [32]. In our primary muscle cell model,
we were not able to detect an increased P-AMPK when cells were
differentiated in 5 mM glucose compared to 25 mM glucose,
consistent with the conclusion that 5 mM glucose is not restrictive
enough in our model. However, a nice increase in P-AMPK was
found when myotubes were differentiated in GAL, suggesting that
GAL medium induced a deprivation of energy, which in turn did
activate AMPK in order to restore energy status of the cells. Thus,
Figure 4. Effect of an acute treatment with galactose medium
on myotube aerobic capacity. A. Basal oxygen consumption rate. B.
State 4 respiration (leak dependent; non-phosphorylating). After basal
oxygen consumption rate measurement, cells were treated with
oligomycin (600 ng/ml) to determine state 4 respiration. C. Maximal
oxygen consumption capacity. After basal and state 4 respiration, cells
were treated with FCCP (1 mM) to determine maximal oxygen
consumption. A–C. Myotubes were differentiated for 7 days in LG
(5 mM glucose). On the 7
th day of differentiation, myotubes were
exposed to HG (25 mM), LG (5 mM glucose) or GAL (10 mM galactose)
for 45 min before measuring basal oxygen consumption rate. Results
are presented as means 6 SEM, n=4, in which each condition was
assessed in 5 replicates.
doi:10.1371/journal.pone.0028536.g004
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myotubes could be the result of an increased AMPK phosphor-
ylation. Other studies will be needed to test this hypothesis.
To test if an acute treatment with GAL could have the same
effect as differentiating the cells for 7 days in GAL, myotubes were
differentiated for 7 days in LG medium and then acutely treated
for 45 min with HG, LG or GAL before OCR measurement. This
acute treatment with GAL was not sufficient to increase OCR
compared to LG or HG treatments. This may be attributed to the
fact that glycolytic intermediates would not be completely depleted
after a 45 min incubation in GAL medium. Taken together, those
results show that differentiating human primary myotubes in GAL
for 7 days could be an easy way to improve the aerobic capacity of
these cells and decrease their reliance on anaerobic glycolysis.
An unexpected and intriguing finding was the increase in non-
mitochondrial OCR in myotubes differentiated in GAL compared
to HG. Extra-mitochondrial sites for oxygen consumption include
the nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase, nitric oxide synthase, and the xanthine oxidase.
Measurement of the cell redox environment with the MTT assay
is based on a reaction in which the formed NAD(P)H reduces
tetrazolium (MTT) reagent to a blue formazan. The intensity of
the reduced product colour is thus proportionate to the NAD(P)
+/
NAD(P)H concentration in the cells [39]. Since the redox
environment measured with the MTT assay was significantly
lower in LG and GAL cells compared to HG cells, this could
indicate a decrease in reduced pyridine nucleotide levels in LG
and GAL myotubes compared to HG myotubes. A similar
decrease in redox state was also found by others in HeLA cells
grown in 10 mM galactose compared to 25 mM glucose [15].
Further studies are needed to directly assess NAD(P)H level and
NAD(P)H oxidase activity to confirm this hypothesis.
Galactose medium is often used to study the effect of
mitochondrial toxins in cancer cells [13,23,24] and has also been
used to examine mitochondrial dysfunction in primary skin
fibroblasts derived from patients with defect in mitochondrial
function [20]. In the present study, we have shown, not only that
GAL is able to increase the oxidative metabolism of healthy
human primary muscle cells, but also that GAL can be used to
identify mitochondrial dysfunction in primary muscle cells derived
from post-diabetic patients. Indeed, unlike myotubes derived from
matched obese non-diabetic subjects, myotubes derived from post-
diabetic patients were not able to increase their oxygen
consumption rate when differentiated in GAL. Thus, in spite of
the fact that there was no difference in OCR between obese non-
diabetic myotubes and post-diabetic myotubes when differentiated
in LG or HG, the GAL media was able to highlight a decreased
oxidative capacity in post-diabetic myotubes compared to obese
non-diabetic myotubes. Other studies have described a decrease in
oxidative metabolic capacity in myotubes derived from diabetic
patients as indicated by a decrease in citrate synthase activity [7]
and a decrease in lipid oxidation capacity [5,9]. Myotubes derived
from post-diabetic subjects are also known to have a decreased
oxidative capacity when challenged with a high glucose medium
(decreased mitochondrial content, decreased citrate synthase and
COX activities) compared to myotubes derived from matched
Figure 5. Absence of an increase in basal oxygen consumption in post-diabetic myotubes differentiated in galactose media. A. Basal
oxygen consumption rate. *, p,0.05, GAL vs HG and LG. #,p ,0.05, post-diabetic vs obese. B. State 4 respiration (leak dependent; non-
phosphorylating). After basal oxygen consumption rate measurement, cells were treated with oligomycin (600 ng/ml) to determine state 4
respiration. C. Maximal oxygen consumption capacity. After basal and state 4 respiration, cells were treated with FCCP (1 mM) to determine maximal
oxygen consumption. D. Non-mitochondrial oxygen consumption rate. After basal, state and maximal respiration, cells were treated with antimycin
(4 mM) to determine non-mitochondrial oxygen consumption. ##,p ,0.001, post-diabetic vs obese. A–D. Myotubes were differentiated for 7 days in
HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose). Results are presented as means 6 SEM, n=5, in which each condition was
assessed in 5–6 replicates.
doi:10.1371/journal.pone.0028536.g005
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oxidative capacity [5,9,40], no difference in OCR was found in
the present study between obese non-diabetic and post-diabetic
myotubes differentiated in either HG or LG. This is presumably
due to the fact that under these conditions, myotubes were highly
glycolytic rendering it more difficult to detect a decrease in OCR
in post-diabetic compared to obese non-diabetic myotubes.
However, the GAL medium was able to identify decreased
OCR in post-diabetic myotubes, revealing the utility of this
approach to detect mitochondrial dysfunction in vitro. Our results
also confirm that post-diabetic myotubes display an abnormal
metabolic flexibility when challenged with different substrates
(here with galactose) as previously published by others who studied
myotubes derived from (post-)diabetic, insulin resistant or obese
patients when challenged with high fat levels [9,11,41] or high
glucose levels [40]. In the present study, the lack of an increase in
OCR in post-diabetic myotubes appears to be related to unaltered
COX expression or activity levels or AMPK phosphorylation.
Another study showed that myotubes derived from diabetic
patients lack the capacity to activate the AMPK pathway
(measured as acetyl-CoA carboxylase phosphorylation) in response
to of palmitate, leading to an absence of any increase in myotubes
palmitate oxidation [9]. It seems that myotubes derived from (post-)
diabetic patients have a impaired AMPK activity in response to
different AMPK-stimulating agents. Other studies will be needed to
determine whether AMPK stimulation is truly impaired in (post-)
diabetic muscle and to determine the mechanisms causing AMPK
‘‘dysfunction’’.
Interestingly, we also found a significant decrease in non-
mitochondrial OCR in post-diabetic myotubes compared to
matched obese non-diabetic myotubes, independently of the
source of carbohydrates used in the differentiation medium. This
result is in accordance with a study from our group showing
perturbations in NADPH production due to an impaired glucose-
6-phosphate dehydrogenase in post-diabetic myotubes [42]. This
could be due to a defect in the pentose phosphate pathway in post-
diabetic myotubes. Another hypothesis explaining the lower non-
mitochondrial OCR in post-diabetic myotubes compared to obese
control myotubes is a decrease in NADPH oxidase protein content
or activity. NADPH oxidase produces superoxide by coupling
their electrons to oxygen. Thus this is an enzyme involved in
reactive oxygen species production (ROS). Interestingly, the
measurement of ROS (by the DCFH-DA assay) in post-diabetic
and obese non-diabetic myotubes showed lower ROS content in
Figure 6. Absence of an increase in cytochrome C oxidase activity and AMPK phosphorylation in post-diabetic myotubes
differentiated in galactose media. A. Mitochondrial yield measured in post-diabetic myotubes differentiated for 7 days in HG (25 mM glucose),
LG (5 mM glucose) or GAL (10 mM galactose). Mitochondrial yield was determined as mitochondrial protein content per total cellular protein
content. Results are presented as means 6 SEM, n=4. *, p,0.05, LG vs HG, **, p,0.01 LG vs GAL. B. Cytochrome C oxidase activity measured in
isolated mitochondria from post-diabetic myotubes differentiated for 7 days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose).
Results are presented as means 6 SEM, n=4. *, p,0.05, GAL vs HG and LG. C. Top panel: representative Western blot of Complex IV expression in
post-diabetic myotubes differentiated for 7 days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose). Beta-actin was used as a
loading control. Bottom panel: quantification by densitometry of complex IV expression. Data are presented normalized to beta-actin expression.
Data are shown as mean 6SEM, n=4. D. Left panel: representative Western blot of P-AMPK expression in post-diabetic myotubes differentiated for 7
days in HG (25 mM glucose), LG (5 mM glucose) or GAL (10 mM galactose). Beta-actin was used as loading controls. Right panels: quantification by
densitometry of P-AMPK. Data are presented normalized to beta-actin and AMPKa2 expression. Data are shown as mean 6SEM, n=4.
doi:10.1371/journal.pone.0028536.g006
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underlying this phenomenon was not the purpose of our study and
needs further investigation.
To our knowledge, this is the first study to test the impact of
different carbohydrate sources on human myotube bioenergetics.
Furthermore, this is the first study that has directly assessed oxygen
consumption rate in vitro in myotubes derived from post-diabetic
patients and demonstrated decrease oxygen consumption rates in
post-diabetic myotubes compared to obese non-diabetic myotubes.
Moreover, we have shown that differentiating cells in GAL is an
excellent model system to investigate the mitochondrial bioener-
getics of human myotubes derived from patients with a history of
T2DM. The use of this model could enable further research to
better understand the molecular mechanisms leading to mito-
chondrial dysfunction during the development of insulin resistance
and other metabolic disorders in skeletal muscle.
Materials and Methods
Ethics statement
All participants gave informed consent and the experimental
protocol was approved by the Human Research Ethics Commit-
tees of the Ottawa Hospital and the University of Ottawa Heart
Institute.
Muscle biopsy and primary human muscle cell culture
Biopsies of vastus lateralis were obtained from 7 lean and
healthy participants (male/female: 6/1, age: 41 years 66.7, BMI
(Body Mass Index): 20.8 kg/m
2 60.5) and from 5 obese non-
diabetic persons (male/female: 4/1, age: 55 years 62.1, BMI:
39.2 kg/m
2 61.3) and 5 obese post-diabetic patients (male/
female: 4/1, age: 54 years 62.3, BMI: 36.6 kg/m
2 61.3) after
local anesthesia, using a 5 mm Bergstrom needle (Opitek,
Glostrup, Denmark) as described previously by Costford et al
[40]. The post-diabetic patients had a documented history of
obesity-associated T2DM prior to a 26-week standard clinical
weight loss program at the Ottawa Hospital Weight Management
Clinic and were no longer diabetic after the weight loss program
(blood glucose ,6.1 mmol/l and HbA1c ,5.7%). Characteriza-
tion of primary muscle cells from the obese non-diabetic and the
obese post-diabetic participants was previously published by our
lab [40].
Subjects were fasted for 12 hours and refrained from physical
activity for three days prior to the biopsy. 40 mg of the muscle
biopsy were processed for satellite cell isolation and culture. The
muscle biopsy was minced, subjected to a 30 minutes trypsin
digestion and plated in Ham’s F-10 medium supplemented with
15% Foetal Bovine Serum (FBS, Gibco, Burlington, ON, Canada),
0.5 mg/ml BSA, 1 mM dexamethazone (Invitrogen, Burlington,
ON, Canada), 10 ng/ml Epidermal Growth Factor (EGF,
Invitrogen, Burlington, ON, Canada) and 25 pM insulin (Sig-
ma–Aldrich, Oakville, ON, Canada), and maintained in 37uCi n
humidified 95% air 5% CO2. Muscle satellite cells were isolated at
,80% confluency using an immuno-based magnetic sorting
technique as previously described [40]. Isolated primary muscle
cells were grown in Ham’s F-10 (6.11 mM glucose) (Gibco,
Burlington, ON, Canada) supplemented with 12.5% FBS, 1 mM
dexamethazone, 10 ng/ml EGF, 25 pM insulin, 16 antibiotic-
antimycotic (Gibco, Burlington, ON, Canada) and 2.5 mg/ml
gentamycin (Growth Medium, GM) to ,90% confluency prior to
differentiation in either low glucose DMEM (5.5 mM glucose,
supplemented with 1 mM sodium pyruvate, 25 pM insulin, 2%
horse serum, 16 antibiotic-antimycotic and 2.5 mg/ml gentamy-
cin) (LG, Gibco, Burlington, ON, Canada), galactose DMEM
(10 mM galactose (Sigma–Aldrich, Oakville, ON, Canada), 1 mM
sodium pyruvate, supplemented with 25 pM insulin, 2% horse
serum, 1% antibiotic-antimycotic and 2.5 mg/ml gentamycin)
(GAL) or high glucose DMEM (25 mM glucose, supplemented
with 1 mM sodium pyruvate, 25 pM insulin, 2% horse serum, 1%
antibiotic-antimycotic and 2.5 mg/ml gentamycin) (HG) for 7 days
prior to experimentation. The choice of 10 mM galactose was
based on previous published studies on other cell lines [13,14,15].
For acute treatments (Figure 4), myotubes were differentiated in
LG for 7 days, and then incubated for 45 min in HG, LG or GAL
prior to experimentation.
Immunofluorescence staining and fusion index
In order to calculate the fusion index, cells differentiated in HG,
LG or GAL for 7 days were subjected to a desmin immunoflu-
orescence staining as previously described [8]. The fusion index
was determined as the number of nuclei in differentiated myotubes
(desmin positive cells with more than 2 nuclei) as a percentage of
the total number of nuclei in muscle cells (desmin positive cells)
[43].
Western Blots
Cell lysates were quantified for protein content and 30 mgo f
protein were separated by 8% SDS-polyacrylamide gel electro-
phoresis and then transferred to a nitrocellulose membrane.
Following primary antibodies were used: monoclonal anti-
troponin T (Sigma–Aldrich, Oakville, ON, Canada), anti-complex
III (Invitrogen, Burlington, ON, Canada), anti-SDHA (succinate
dehydrogenase, Santa Cruz Biotechnology, Santa Cruz, CA,
USA), anti-complex IV (MitoSciences, Eugene, OR, USA), anti-
AMPK a2 (Upstate, Lake Placid, NY, USA) and polyclonal anti-b-
actin (Cell signaling, Pickering, ON, Canada) diluted 1/1000.
Polyclonal anti-phospho-AMPK (Cell signaling, Pickering, ON,
Canada) was diluted at 1/500. The secondary antibodies were
anti-mouse and anti-rabbit antibodies coupled to horseradish
peroxidase, respectively. Proteins were visualized using an
enhanced luminescent reagent and exposed to autoradiograph
film. b-actin and Troponin T were used as a loading control and a
marker of myotube differentiation, respectively. Expression of
proteins was quantified by density analysis using ImageJ Launcher
Software.
Cell redox environment
Cell redox environment following 7 days of differentiation in
HG, LG or GAL was assessed using the MTT Assay Kit
(Millipore, Billerica, MA, USA).
ATP assay
ATP content in myotubes differentiated in HG, LG or GAL for
7 days was assessed using the StayBrite ATP assay kit (Biovision,
Mountain View, CA, USA).
HPLC Determination of Cellular Lactate Release
Myoblasts were seeded at 200,000 cells per well of a 6-well
plate. Upon reaching ,90% confluency, cells were differentiated
in their respective differentiation medium (HG, LG or GAL) for 7
days. On the 6
th day post differentiation the medium was changed
and then collected 24 h later for analysis. For experiments, 1 ml of
media was treated with 50 ml of 0.5% (v/v) perchloric acid
solution. Samples were then centrifuged at 12,000 g for 10 min
and subsequently filtered with a sterile syringe and 0.2 mm
filtration unit. Samples were injected into an Agilent 1100 Series
HPLC system equipped with a C18 reverse phase hydrophilic
Galactose Effects on Human Muscle Cell Metabolism
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Lactate was detected using an Agilent variable wavelength
detector set to 210 nm. The retention time of lactate was
confirmed by injection standard lactate solutions. Lactate levels
were quantified by injection varying concentrations of standard
lactate solutions and the use of Agilent ChemStation software.
Extracellular Flux (XF) Analysis of Cellular Metabolic
Characteristics
20,000 cells per well were plated in a XF24-well plate (Seahorse
Bioscience, North Billerica, MA, USA), grown to ,90%
confluency and differentiated for 7 days in HG, LG or GAL.
Myotubes were then incubated for 45 min at 37uC at ambient
CO2 in HCO3-free DMEM (pH 7.4) containing 4 mM glutamine,
1 mM pyruvate and 25 mM glucose (HG), or 5 mM glucose (LG)
or 10 mM galactose (GAL). Oxygen consumption rates (OCR)
were determined in situ using a Seahorse Extracellular Flux
Analyzer. Baseline oxygen consumption rate was measured 3 times
for 4 min each separated by a 2 min wait and a 2 min mix.
Following the measurement of basal respiration, oligomycin
(600 ng/ml) (Sigma–Aldrich, Oakville, ON, Canada) was injected
into each well, followed by 3 cycles of: 2 min mix, 2 min wait and
4 min measurement to measure state 4 (non-phosphorylating)
respiration. Then, FCCP (1 mM) (Sigma–Aldrich, Oakville, ON,
Canada) was injected into each well, followed by 3 cycles of: 2 min
mix, 2 min wait and 2.5 min measurement to measure maximal
respiration. Finally, antimycin A (4 mM) (Sigma–Aldrich, Oakville,
ON, Canada) was injected into each well, followed by 3 cycles of:
2 min mix, 2 min wait and 3 min measurement to measure
extramitochondrial O2 consumption. The cells were then collected
for determinations of protein content (Bradford assay). The data
are presented as: mitochondrial OCR (basal, oligomycin or FCCP
OCR are reported following the subtraction of OCR in the
presence of antimycin) and expressed per mg of total cellular
protein.
Mitochondrial yield, Citrate Synthase (CS) and COX
Activity Assays
Myoblasts were grown in a 75-cm
2 flask to ,90% confluency
and then differentiated in their respective differentiation media
(HG, LG or GAL) for 7 days. Intact mitochondria were isolated
using a kit (MITOISO; Sigma–Aldrich, Oakville, ON, Canada).
Mitochondrial and total cellular protein levels were determined by
a BCA (bicinchoninic acid) assay. Mitochondrial yield was
expressed as mg of mitochondrial protein per mg of total cellular
protein. CS activity was assayed in lysed mitochondria using a
kit (CSO720; Sigma–Aldrich, Oakville, ON, Canada) with
0.5 mmol/l oxaloacetate, 0.3 mmol/l acetyl-CoA, 0.1 mmol/l of
5, 59-dithiobis 2-nitro-benzoic acid. Enzyme activity was moni-
tored by recording the changes in absorbance at 412 nm over
1.5 min. COX activity was measured in intact mitochondria using
a kit (Cytocox1; Sigma–Aldrich, Oakville, ON, Canada) based on
the decrease in absorbance over 3 min at 550 nm of ferrocyto-
chrome C caused by its oxidation to ferricytochrome C by COX.
Enzyme activities were normalized to protein content.
Cardiolipin staining and quantification
10N-nonyl acridine orange (NAO, Sigma–Aldrich, Oakville,
ON, Canada) staines the mitochondrial phospholipid cardiolipin
[44]. NAO is used as a mitochondrial content marker since it is
essentially independent of the mitochondrial membrane potential
[45]. After differentiation in HG, LG and GAL for 7 days,
myotubes were fixed with paraformaldehyde at 4% in PBS for
10 min, and then cardiolipin was stained by NAO (1 mM) for
30 min, in the dark, at room temperature. The dye was then
washed 3 times with PBS, and mitochondrial content quantified in
a fluorometer (emission: 535 nm, excitation: 485 nm).
Statistical analyses
Data are presented as mean 6SEM. Statistical analyses were
performed using Statview 5.0 (SAS institute Inc, Cary, NC, USA).
One-way or 2-ways ANOVAs with Fisher’s protected least
significant difference post-hoc test were used to assess statistical
differences. P,0.05 was considered to be significant.
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